Target intelligence / Profile preview

Helicase-like transcription factor (HLTF)

Target
HLTF
Molecular classification
Transcription factor, Chromatin remodeler, E3 ubiquitin ligase, DNA-binding protein, dsDNA translocase, Helicase-like enzyme
01

Overview

Helicase-like transcription factor (HLTF) is a multifunctional enzyme and chromatin remodeler belonging to the SWI/SNF family, with roles in DNA repair, transcription regulation, and protein remodeling at stalled replication forks. HLTF contains a HIRAN DNA-binding domain, a SWI/SNF-like helicase domain, and a RING finger domain conferring E3 ubiquitin ligase activity. Through its dsDNA translocase activity, HLTF orchestrates fork remodeling and regression to facilitate template-switching-based, error-free DNA damage bypass. HLTF is considered a tumor suppressor, frequently inactivated via promoter methylation or sporadic alternative splicing in colorectal and gastric cancers. Loss of HLTF function compromises cellular resistance to DNA damage and is associated with increased sensitivity to UV and genotoxic agents[1][2][3][4].

Other names
HIP116ARNF80SMARCA3SNF2L3ZBU1HLTF1HIP116RING finger protein 80RING-type E3 ubiquitin transferase HLTFSWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3Sucrose nonfermenting protein 2-like 3DNA-binding protein/plasminogen activator inhibitor 1 regulator
02

Biological functions

DNA repairTranscription regulationChromatin remodelingReplication fork reversal/remodelingProtein displacement/remodeling at replication forks
03

Disease associations

Cancer (tumor suppressor, inactivated by promoter methylation in colorectal and gastric cancer)Other (cellular sensitivity to DNA-damaging agents when HLTF is inactivated)
04

Safety considerations

Tumor suppressor loss (its inactivation may predispose to cancer development)Potential genotoxicity (interference with DNA repair pathways could increase cellular sensitivity to DNA-damaging agents)
05

Biomarkers

HLTF expression/silencing (methylation status or splice variant can be used as a biomarker in certain cancers)

Beyond the preview

Go deeper on Helicase-like transcription factor (HLTF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicase-like transcription factor (HLTF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call